Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo.

Buijs JT, Rentsch CA, van der Horst G, van Overveld PG, Wetterwald A, Schwaninger R, Henriquez NV, Ten Dijke P, Borovecki F, Markwalder R, Thalmann GN, Papapoulos SE, Pelger RC, Vukicevic S, Cecchini MG, Löwik CW, van der Pluijm G.

Am J Pathol. 2007 Sep;171(3):1047-57.

2.

Bone morphogenetic proteins and its receptors; therapeutic targets in cancer progression and bone metastasis?

Buijs JT, Petersen M, van der Horst G, van der Pluijm G.

Curr Pharm Des. 2010;16(11):1291-300. Review.

PMID:
20166979
3.

Bone morphogenetic proteins.

Chen D, Zhao M, Mundy GR.

Growth Factors. 2004 Dec;22(4):233-41. Review.

PMID:
15621726
4.

Prostate tumor cell plasticity: a consequence of the microenvironment.

Yates C.

Adv Exp Med Biol. 2011;720:81-90. doi: 10.1007/978-1-4614-0254-1_7. Review.

5.

RANK-mediated signaling network and cancer metastasis.

Chu GC, Chung LW.

Cancer Metastasis Rev. 2014 Sep;33(2-3):497-509. doi: 10.1007/s10555-013-9488-7. Review.

6.

The role of epithelial plasticity in prostate cancer dissemination and treatment resistance.

Bitting RL, Schaeffer D, Somarelli JA, Garcia-Blanco MA, Armstrong AJ.

Cancer Metastasis Rev. 2014 Sep;33(2-3):441-68. doi: 10.1007/s10555-013-9483-z. Review.

Items per page

Supplemental Content

Support Center